These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 673877)

  • 1. [Mortality from cardiovascular diseases in diabetics as a function of methods of hypoglycemic treatment].
    Królewski AS; Czyzyk A; Janeczko D; Kopczyński J
    Pol Arch Med Wewn; 1978 Mar; 59(3):285-93. PubMed ID: 673877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sex differences in cardiovascular mortality of diabetics].
    Heyden S
    Dtsch Med Wochenschr; 1976 May; 101(20):789-93. PubMed ID: 1261427
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 4. [Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised].
    Canivet J; Deuil R; Eschwege E; Hazard J; Lubetzki J; Tchobroutsky G; Valleron A
    Presse Med (1893); 1971 Dec; 79(53):2437-44. PubMed ID: 5156529
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
    Goldner MG; Knatterud GL; Prout TE
    JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.
    Bianchi C; Miccoli R; Daniele G; Penno G; Del Prato S
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S342-8. PubMed ID: 19875578
    [No Abstract]   [Full Text] [Related]  

  • 7. Rethinking treatment for patients with diabetes and cardiovascular disease.
    Mitka M
    JAMA; 2002 May; 287(19):2488-91. PubMed ID: 12020317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atherogenic risk in diabetes: study of arteriosclerotic complications and their relationship with prolonged hypoglycemic treatment].
    Baraldi B; Cristini PD; Maestri G; Maj F; Cocuzza E; Angeli G
    Clin Ter; 1978 Jul; 86(1):37-53. PubMed ID: 743852
    [No Abstract]   [Full Text] [Related]  

  • 9. The UGDP study.
    Salsburg DS
    JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incidence of coronary disease in diabetics in relation to methods of hypoglycemic treatment].
    Królewski AS; Czyzyk A; Janeczko D; Puncewicz B; Kopczyński J
    Pol Arch Med Wewn; 1978 Mar; 59(3):295-304. PubMed ID: 673878
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral hypoglycaemic agents and cardiovascular deaths in diabetes].
    Drury MI; Timoney FJ
    Acta Diabetol Lat; 1972; 9(4):645-50. PubMed ID: 4657695
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-diabetic therapy and cardiovascular risk].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
    [No Abstract]   [Full Text] [Related]  

  • 14. The fate of diabetic patients--epidemiological study. III. Prevalence of coronary heart disease in diabetics depending on the method of hypoglycaemic treatment. Warsaw.
    Królewski A; Czyźyk A; Kopczynski J; Janeczko D; Puncewicz B
    Acta Med Pol; 1978; 19(3):363-71. PubMed ID: 735877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rehabilitation of oral hypoglycemic agents].
    Biron P
    Union Med Can; 1975 Sep; 104(9):1421-4. PubMed ID: 1179546
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
    Lamanna C; Monami M; Marchionni N; Mannucci E
    Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin treatment and diabetic vascular complications.
    Brodsky JB; Ring C; Palmer JP
    JAMA; 1979 Jun; 241(26):2783-4. PubMed ID: 448830
    [No Abstract]   [Full Text] [Related]  

  • 18. [SGLT2 inhibition in type 2 diabetes. New study data for reducing cardiovascular risk].
    MMW Fortschr Med; 2015 Oct; 157(18):86-7. PubMed ID: 26985517
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.